Catherine Shaker MS/CCC-SLP, BCS-S, Author at Dysphagia Cafe

1 POSTS 0 COMMENTS

Catherine S. Shaker MS/CCC-SLP, BCS-S is a Pediatric Speech-Language Pathologist with Florida Hospital for Children in Orlando, FL who has advanced training in clinical/ instrumental assessment and treatment of swallowing and its disorders. With over 39 years’ experience, Ms. Shaker is nationally recognized as an expert in swallowing/feeding across the continuum of pediatric settings, including neonates, medically-fragile infants, and children through school age. She is an ASHA Board Certified Specialist in Swallowing and Swallowing Disorders. Ms. Shaker has been an integral part of large Level III Neonatal Intensive Care Units for over 30 years and is known for her work on Cue-Based Feeding Approaches in the NICU. She has published several manuscripts on NICU intervention, and co-authored The Early Feeding Skills Assessment Tool for NICU Infants with Suzanne Thoyre, PhD, RN of Chapel Hill. She provides Videofluoroscopic Swallow Studies for infants and children, and is certified in Neurodevelopmental Treatment (NDT), trained in Pediatric FEES and Vital Stim as well as SOS (The Sequential Oral Sensory Approach to Feeding). Ms. Shaker lectures both nationally and internationally to physicians, nurses, therapists and families.

Supporting parents feeding preemies: It’s not just about intake

Catherine Shaker MS/CCC-SLP, BCS-S - April 20, 2016

Scroll for Important Safety Information

INDICATIONS AND USAGE:

VARIBAR ® THIN HONEY (barium sulfate) oral suspension, VARIBAR ® NECTAR (barium sulfate) oral suspension, and VARIBAR ® THIN LIQUID (barium sulfate) for oral suspension, are indicated for use in modified barium swallow examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients. VARIBAR ® HONEY (barium sulfate) oral suspension and VARIBAR ® PUDDING (barium sulfate) oral paste are indicated for use in modified barium swallow examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients 6 months of age and older.

IMPORTANT SAFETY INFORMATION:
For Oral Administration. This product should not be used in patients with known or suspected perforation of the GI tract, known obstruction of the GI tract, high risk of aspiration, or hypersensitivity to barium sulfate products. Rarely, severe allergic reactions of anaphylactoid nature have been reported following administration of barium sulfate contrast agents. Aspiration may occur during the modified barium swallow examination, monitor the patient for aspiration.

Please consult full Prescribing Information for VARIBAR products by clicking HERE.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit FDA or call 1-800-FDA-1088.